Consolidated Statement Of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities [Abstract]
Net income	$ 220	$ 217
Depreciation	122	123
Amortization of intangibles	38	65
Amortization of deferred financing charges	4	4
Unremitted earnings of affiliates	6	(8)
Stock compensation expense	11	14
Deferred income taxes	(6)	5
Pension contributions, net	(8)	(56)
Interest payment received on payment-in-kind note receivable	40	26
Change in working capital	(120)	(75)
Other, net	(5)	(22)
Net cash provided by operating activities	302	293
Investing activities [Abstract]
Purchases of property, plant and equipment	(144)	(123)
Acquisition of business		(8)
Principal payment received on payment-in-kind note receivable	35	33
Purchases of marketable securities	(63)	(80)
Proceeds from sales of marketable securities	2	28
Proceeds from maturities of marketable securities	4	7
Proceeds from sale of business	9	1
Other	5	8
Net cash used in investing activities	(152)	(134)
Financing activities [Abstract]
Net change in short-term debt	(5)	(11)
Proceeds from letters of credit	12
Repayment of letters of credit	(8)
Proceeds from long-term debt	23	811
Repayment of long-term debt	(26)	(55)
Deferred financing payments		(17)
Preferred stock redemption		(474)
Dividends paid to preferred stockholders	(6)	(23)
Dividends paid to common stockholders	(24)	(22)
Distributions to noncontrolling interests	(8)	(11)
Repurchases of common stock	(181)	(288)
Payments to acquire noncontrolling interests		(7)
Other	4	7
Net cash used in financing activities	(219)	(90)
Net increase (decrease) in cash and cash equivalents	(69)	69
Cash and cash equivalents - beginning of period	1,256	1,059
Effect of exchange rate changes on cash balances	(84)	(7)
Cash and cash equivalents – end of period	$ 1,103	$ 1,121